Bangkok, Thailand, November 1, 2021 – ZP Therapeutics, a business unit of Zuellig Pharma, Asia’s leading healthcare provider, has already delivered the first 560,000 doses of the Covid-19 Moderna vaccine to the Government Pharmaceutical Organization.
"We are delighted to inform you that we are ready to deliver the first installment of 560,000 doses Moderna COVID-19 vaccine within the specified time frame," Sunaina Kitkasetpaisal, ZP Therapy, Zillic Pharma Thailand, said. "And, as Moderna has confirmed, the remaining 1.9 million doses will be delivered gradually by the end of 2021. The remaining 6.8 million vaccine doses will be distributed in the first quarter of 2022."
"The Company will bring its capabilities and expertise in the storage and distribution of various pharmaceuticals and vaccines, including the adoption of advanced technology in supply chain and cold-chain logistics to maintain the quality of the Covid-19 Moderna vaccine, which must be kept at -20 degrees Celsius to ensure that the vaccine will be transported to the distance hospitals in Thailand," said Ms. Paknalin Bulakul, Executive Chairman of Zuellig Pharma Thailand.
According to Sirikul Methevee Creation, Deputy Director of the Government Pharmaceutical Organization, the GPO has been assigned to be a government agency responsible for purchasing and procuring alternative vaccines. so that people have more options for vaccines In doing so, The Pharmaceutical Organization would like to thank the Association of Private Hospitals and Zuellig Pharma Company Limited for working together to get people to get this vaccine. And, from now on, once the vaccine has passed all inspections, Zuellig Company will distribute it to private hospitals. based on the proportion of each private hospital’s subscription amount
"Since the outbreak of the COVID-19 virus, the Government Pharmaceutical Organization (GPO) has been committed and dedicated to all of its missions, including medicines, vaccines, medical supplies, and preventive devices." Contribute to the Thai public health system. "Reduce morbidity and mortality to propel the economy forward," said the Deputy Director General.
"In the part of the association Advance notice has been given so that each hospital will prepare vaccination services for people who have reserved vaccines and the Private Hospital Association will continue to monitor progress in vaccine delivery with ZP Theraputics closely next," said Dr. Chalerm Hanpanich, President of the Private Hospital Association. The Covid-19 vaccine was developed in order to get alternative vaccines to the public as soon as possible. Moderna is an alternative vaccine that is still very popular. According to clinical trial results in adults who received two doses of the vaccine, it is up to 94 percent effective in preventing COVID-19 infection.
About ZP Theraputics
ZP Theraputics is the industry’s leading trading partner in the healthcare services sector. It employs over 2,500 people and has offices in 13 Asian countries. Through commercial excellence, strong market potential, and strong ethics, we look forward to accelerating the development of patient care solutions and health outcomes. Our commitment is to improve access to health care by implementing fast, flexible, and accurate workflows and striving for excellence in everything we do.
